monitoring DAYBUE sales, NNZ-2591 progress, and any further short-seller activity is critical. thats all you we as a shareholder can do. As i said i earlier i am disgusted to see $10 but such is life. Patience should reward us but 45%+ drop in a year is not telling me anything about exciting times ahead.Short sellers are likely betting on DAYBUE’s potential underperformance, clinical trial risks for NNZ-2591, and a perceived overvaluation from NEU’s high P/E ratio. who knows? I can't see this being under $20 but here we are half the price. .
May be a short squeeze soon.
monitoring DAYBUE sales, NNZ-2591 progress, and any further...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.29 |
Change
0.660(3.97%) |
Mkt cap ! $2.178B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $17.34 | $16.63 | $9.078M | 529.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1334 | $17.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.33 | 2245 | 3 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |